Atomwise Appoints Steve Worland as CEO to Lead AI-Driven Drug Discovery
Atomwise has appointed Steve Worland, Ph.D., as its new Chief Executive Officer. Worland brings over 30 years of experience in biotechnology and pharmaceuticals to the AI-driven drug discovery company.